mesenchymal stem cells from placental amniotic membrane.
Placental amniotic-membrane MSCs are immunomodulatory, anti-inflammatory and paracrine-active mesenchymal cells — the most widely studied cell type in modern regenerative medicine.
The therapeutic value of MSCs from Amniotic Membrane lies less in cells "becoming" new tissue and more in their paracrine signalling — the growth factors and vesicles they release to calm inflammation and recruit the body's own repair. Delivery is matched to the target: intravenous for systemic conditions, or localised where appropriate.
Educational information. MSCs from Amniotic Membrane protocols for several conditions remain investigational; outcomes vary by patient.
GMP-certified regenerative medicine in the heart of the EU — from €3,000–8,000, a fraction of US or German pricing. Personalised protocols for international patients from 50+ countries.
Free medical review